Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Abcellera Biologics Inc. (ABCL)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 269,190,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   AbCellera is a Vancouver, British Columbia-based biotechnology firm that researches and develops human antibodies to address pandemics and common diseases. Co.'s full-stack, artificial intelligence-, or AI, powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. Rather than advancing its own clinical pipeline of drug candidates, Co. forges partnerships with drug developers of all sizes, from pharmaceutical to small biotechnology companies. In a collaboration with Eli Lilly and Company, Co. has applied its technology stack to co-develop LY-CoV555, a potential antibody therapy to treat and prevent COVID-19.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 428,631 712,147 812,147
Total Buy Value $0 $940,311 $1,680,288 $2,196,688
Total People Bought 0 2 2 4
Total Buy Transactions 0 3 4 9
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2025-04-06 2025-01-03 2024-07-05 2023-07-06

   
Records found: 86
  Page 1 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Thermopylae Holdings Ltd. 10% Owner   –       –       •   2025-03-11 4 B $2.16 $742,243 D/D 343,631 56,143,640 2.45     -
   Montalbano John S. Director   –       •      –    2025-03-10 4 B $2.30 $57,500 D/D 25,000 171,000 2.39     -
   Montalbano John S. Director   –       •      –    2025-03-06 4 B $2.34 $140,568 D/D 60,000 146,000 2.39     -
   Thermopylae Holdings Ltd. 10% Owner   –       –       •   2024-12-04 4 GD $0.00 $0 D/D 286,000 55,800,009     -
   Hansen Carl L. G. Chief Executive Officer   •       •       •   2024-11-25 4 OE $2.70 $151,538 D/D 56,125 898,000     -
   Hansen Carl L. G. Chief Executive Officer   •       •       •   2024-09-20 4 OE $2.70 $151,538 D/D 56,125 841,875     -
   Thermopylae Holdings Ltd. 10% Owner   –       –       •   2024-08-29 4 B $2.61 $739,977 D/D 283,516 56,086,009 2.45     -
   Lecault Veronique Chief Operating Officer   •       •      –    2024-06-21 4 OE $0.19 $15,667 D/D 83,334 2,123,456     -
   Hansen Carl L. G. Chief Executive Officer   •       •       •   2024-05-31 4 OE $2.70 $151,538 D/D 56,125 785,750     -
   Hansen Carl L. G. Chief Executive Officer   •       •       •   2024-02-26 4 OE $2.70 $151,538 D/D 56,125 729,625     -
   Thermopylae Holdings Ltd. 10% Owner   –       –       •   2023-12-19 4 GD $0.00 $0 D/D 210,000 55,802,493     -
   Hansen Carl L. G. Chief Executive Officer   •       •       •   2023-11-23 4 OE $2.70 $151,538 D/D 56,125 673,500     -
   Montalbano John S. Director   –       •      –    2023-11-08 4 B $4.46 $44,600 D/D 10,000 86,000 2.39     -
   Montalbano John S. Director   –       •      –    2023-11-06 4 B $4.64 $92,800 D/D 20,000 76,000 2.39     -
   Hayden Michael R Director   –       •      –    2023-09-22 4 B $4.91 $98,200 I/I 20,000 1,323,397 2.1     -
   Lecault Veronique Chief Operating Officer   •       •      –    2023-09-12 4 B $5.19 $103,800 D/D 20,000 2,040,122 2.81     -
   Hansen Carl L. G. Chief Executive Officer   •       •       •   2023-08-24 4 OE $2.70 $151,538 D/D 56,125 617,375     -
   Hayden Michael R Director   –       •      –    2023-08-08 4 B $5.90 $177,000 I/I 30,000 1,303,397 2.1     -
   Hansen Carl L. G. Chief Executive Officer   •       •       •   2023-05-26 4 OE $2.70 $151,538 D/D 56,125 561,250     -
   Booth Andrew Chief Financial Officer   •       –      –    2023-05-26 4 B $6.85 $99,325 D/D 14,500 153,000 2.74     -
   Thermopylae Holdings Ltd. 10% Owner   –       –       •   2023-05-26 4 B $6.52 $997,728 D/D 153,000 56,012,493 2.45     -
   Lecault Veronique Chief Operating Officer   •       •      –    2023-05-05 4 OE $0.19 $47,500 D/D 250,000 2,020,122     -
   Hansen Carl L. G. Chief Executive Officer   •       •       •   2023-02-22 4 OE $2.70 $151,538 D/D 56,125 505,125     -
   Booth Andrew Chief Financial Officer   •       –      –    2022-12-20 4 GD $0.00 $0 D/D 50,000 138,500     -
   Booth Andrew Chief Financial Officer   •       –      –    2022-12-20 4 OE $0.19 $9,500 D/D 50,000 188,500     -

  86 Records found
  1  2  3  4   
  Page 1 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed